Biotest AG
BIESF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1,150,586 | $1,094,965 | $1,018,089 | $1,147,894 |
| - Cash | $0 | $107,800 | $24,700 | $66,300 |
| + Debt | $0 | $597,200 | $0 | $624,300 |
| Enterprise Value | $1,150,586 | $1,584,365 | $993,389 | $1,705,894 |
| Revenue | $124,200 | $203,500 | $150,700 | $156,800 |
| % Growth | -39% | 35% | -3.9% | – |
| Gross Profit | $14,100 | $52,900 | $29,200 | $51,100 |
| % Margin | 11.4% | 26% | 19.4% | 32.6% |
| EBITDA | -$9,525 | $11,775 | $2,200 | $34,850 |
| % Margin | -7.7% | 5.8% | 1.5% | 22.2% |
| Net Income | -$21,400 | -$3,500 | -$9,300 | $9,700 |
| % Margin | -17.2% | -1.7% | -6.2% | 6.2% |
| EPS Diluted | -0.55 | -0.094 | -0.25 | 0.24 |
| % Growth | -485.1% | 62.4% | -204.2% | – |
| Operating Cash Flow | – | $37,500 | -$23,400 | $58,400 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $8,800 | -$23,400 | $58,400 |